Notice of Clarification: Research Strategy page limit for PAR-18-548, Clinical Validation of a Candidate Biomarker for Neurological Disease (U44 Clinical Trial Optional)

Sponsor: National Institute of Neurological Disorders and Stroke

( Notice of Clarification: Research Strategy page limit for PAR-18-664, Clinical Valid

Sponsor: National Institute of Neurological Disorders and Stroke

Notice of Clarification: Research Strategy page limit for PAR-18-550, Analytical Validation of a Candidate Biomarker for Neurological Disease (U01) (Clinical Trial Optional)

Sponsor: National Institute of Neurological Disorders and Stroke

Notice of Clarification: Research Strategy page limit for PAR-18-549, Analytical Validation of a Candidate Biomarker for Neurological Disease (U44 Clinical Trial Optional)

Sponsor: National Institute of Neurological Disorders and Stroke

BRAIN Initiative: Research on the Ethical Implications of Advancements in Neurotechnology and Brain Science (R01 Clinical Trial Optional)

Sponsor: National Institutes of Health

Award: Issuing IC and partner components intend to commit an estimated total of $3 million in FY2019 to fund up to eight awards.

Due Date: February 4, 2019, October 9, 2019, and October 9, 2020, by 5 p.m. local time of applicant organization.

Innovation Corps (I-Corps) at NIH Program for NIH and CDC Translational Research (Admin Supp Clinical Trial Not Allowed)

Sponsor: National Institutes of Health

Award: NIH and CDC intend to commit up to $1.2 million in each fiscal year (FY 2019-2021) to fund up to 24 awards per year (72 awards over three fiscal years).

Due Date: November 19, 2018; January 28, 2019, by 5 p.m. local time of applicant organization.

Request for Information (RFI) on the Proposed Funding Priorities for Neuroscience Research, Input on Cross-Cutting Opportunities (NIH Neuroscience Blueprint)

Sponsor: National Institutes of Health

New NIH Peer Review Videos for Applicants

Sponsor: Center for Scientific Review

Notice of Intent to Issue the Funding Opportunity Announcement for Bioengineering Research Grants (BRG) (R01 Clinical Trial Required)

Sponsor: National Institute of Biomedical Imaging and Bioengineering

Notice of Intent to Issue the Funding Opportunity Announcement for Bioengineering Research Grants (BRG) (R01 Clinical Trial Not Allowed)

Sponsor: National Institute of Biomedical Imaging and Bioengineering

Notice of Intent to Issue the Funding Opportunity Announcement for Bioengineering Research Partnerships (U01 Clinical Trial Required)

Sponsor: National Institute of Biomedical Imaging and Bioengineering

Notice of Intent to Issue the Funding Opportunity Announcement for Bioengineering Research Partnerships (U01 Clinical Trial Not Allowed)

Sponsor: National Institute of Biomedical Imaging and Bioengineering

Notice of Joint DMS/NLM Initiative on Generalizable Data Science Methods for Biomedical Research

Sponsor: National Library of Medicine

Collaborative Research in Computational Neuroscience (CRCNS) Innovative Approaches to Science and Engineering Research on Brain Function

Sponsor: National Institutes of Health

Notice of Correction of PA-18-870, "BRAIN Initiative: Development Optimization, and Validation of Novel Tools and Technologies for Neuroscience Research (STTR) (R41/R42 - Clinical Trials Not Allowed)”

Sponsor: National Institute of Mental Health